The use of a forecasting system for predicting exacerbations of COPD

Study identifier:D6256M00017

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

The use of a forecasting system for predicting exacerbations of COPD: effect on symptoms and hospitalisation and relevance of viral infections

Medical condition

Chronic obstructive pulmonary disease (COPD)

Phase

N/A

Healthy volunteers

Yes

Study drug

-

Sex

All

Actual Enrollment

98

Study type

Interventional

Age

40 Years +

Date

Study Start Date: 01 Aug 2008
Primary Completion Date: 01 Mar 2009
Study Completion Date: 01 Mar 2009

Study design

Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention

Verification:

Verified 01 Nov 2010 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria